PARP-1/2-IN-2

This small molecule is a potent dual inhibitor of PARP1/2 and CDK12, demonstrating strong activity in cellular assays and in vivo models. It disrupts DNA damage repair pathways, leading to anti-proliferative effects, cell cycle arrest, and apoptosis in triple-negative breast cancer (TNBC) research.